TSN expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.30550056612833E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.13859998996224E-09 |
Normal-vs-Stage2 |
2.33089999968072E-07 |
Normal-vs-Stage3 |
5.20229970213393E-10 |
Normal-vs-Stage4 |
2.02840000351756E-08 |
Stage1-vs-Stage2 |
1.222000E-01 |
Stage1-vs-Stage3 |
2.022400E-02 |
Stage1-vs-Stage4 |
6.248000E-02 |
Stage2-vs-Stage3 |
7.705600E-01 |
Stage2-vs-Stage4 |
7.685800E-01 |
Stage3-vs-Stage4 |
9.590600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.76530037651912E-10 |
Normal-vs-AfricanAmerican |
4.23199997268142E-09 |
Normal-vs-Asian |
1.740480E-03 |
Caucasian-vs-AfricanAmerican |
3.478000E-01 |
Caucasian-vs-Asian |
5.658600E-01 |
AfricanAmerican-vs-Asian |
8.066600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.40032430095971E-12 |
Normal-vs-Female |
1.62189999997064E-06 |
Male-vs-Female |
1.376190E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.35809999971082E-07 |
Normal-vs-Age(41-60Yrs) |
6.64429955499202E-10 |
Normal-vs-Age(61-80Yrs) |
1.52780010864717E-10 |
Normal-vs-Age(81-100Yrs) |
6.29509999999778E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.429000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.543190E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.522000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.174400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.791800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.942200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.714100E-02 |
Normal-vs-Grade 2 |
1.24680000002098E-06 |
Normal-vs-Grade 3 |
1.13860032513458E-11 |
Normal-vs-Grade 4 |
2.75980349684346E-11 |
Grade 1-vs-Grade 2 |
7.719800E-01 |
Grade 1-vs-Grade 3 |
1.668990E-01 |
Grade 1-vs-Grade 4 |
4.859600E-02 |
Grade 2-vs-Grade 3 |
2.118200E-03 |
Grade 2-vs-Grade 4 |
1.418850E-04 |
Grade 3-vs-Grade 4 |
1.025630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.96834999999229E-05 |
Normal-vs-ccB subtype |
8.61311022504196E-13 |
ccA subtype-vs-ccB subtype |
3.79770000002999E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.84859999530218E-08 |
Normal-vs-N1 |
3.075600E-02 |
N0-vs-N1 |
7.099000E-01 |
|
|